Lu Peng sold $602K of PHVS
Lu Peng (President) sold 15,000 shares of Pharvaris N.V. (PHVS) at $40.13 ($0.60M total) on 2026-09-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and likely already priced in; traders should focus on larger catalysts.
Market read
Primary insider sale with limited material impact; low trading relevance.
What to watch
Potential upcoming corporate actions or financing needs not disclosed.
Background
Form 4 filings disclose insider transactions; a 10b5‑1 plan sale is pre‑arranged and often non‑informative.
Ticker impact
President Lu Peng sold 15,000 shares for $602K via a 10b5-1 plan, reducing his holdings to 65,179 shares.
minor downward pressure or flat price action
The sale amount is modest relative to market cap and follows a pre‑arranged plan, limiting informational value.
Market effects
No broader sector impact; insider sale is company‑specific.
Limited to US biotech investors; no regional ripple.
Minimal global relevance.
Counterpoint
The sale could be routine and unrelated to fundamentals; investors may ignore it.
Key entities
- CompanyPharvaris N.V.
Biotech firm listed on Nasdaq under ticker PHVS.
- InsiderLu Peng
President of Pharvaris, reporting a sale of 15,000 shares.
